Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes

Infection and Immunity

Volumn 65, Issue 6, 1997, Pages 2060-2066

  Wuorela, Maarit ^a,b   Jalkanen, Sirpa ^a   Kirveskari, Juha ^a   Laitio, Päivi ^a   Granfors, Kaisa ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYLOSING SPONDYLITIS; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEUKOCYTE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SEROTYPE; YERSINIA ENTEROCOLITICA;

EID: 0030914431     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.6.2060-2066.1997     Document Type: Article

References (52)

1. Aho, K., P. Ahvunen, A. Lassus, K. Sievers, and A. Tiilikainen. 1974. AHL- 827 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease. Arthritis Rheum. 17:521-526.
2. Amor, B., A. Kahan, and A. Georgiadis. 1978. Transient loss of HLA-B27. Lancet i:284.
3. Berger, A. E., J. E. Davis, and P. Cresswell. 1982. Monoclonal antibody to HLA-A3. Hybridoma 1:87-90.
4. Ellis, S. A., C. Taylor, and A. McMichael. 1982. Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum. Immunol. 5:49-59.
5. El-Zaatari, F. A. K., K. C. Sams, and J. D. Taurog. 1990. In vitro mutagenesis of HLA-B27, Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain. J. Immunol. 144:1512-1517.
6. El-Zaatari, F. A. K., and J. D. Taurog. 1992. In vitro mutagenesis of HLA- B27: single and multiple amino acid substitutions at consensus B27 sites identify distinct monoclonal antibody-defined epitopes. Hum. Immunol. 33: 243-248.
7. Gao, X.-M., P. Wordsworth, A. J. McMichael, M. M. Kyaw, M. Seifert, D. Rees, und G. Dougan. 1996. Homocysteine modification of HLA antigens and its immunological consequences. Eur. J. Immunol. 26:1443-1450.
8. Geczy, A. F., L. E. McGuigan, J. S. Sullivan, and J. P. Edmonds. 1986. Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis. J. Exp. Med. 164:932-937.
9. Gemski, P., J. Lazere, and I. Casey. 1980. Plasmid associated with the pathogenicity and calcium dependence of Yersinia enterocolitica. Infect. Immun. 27:682-685.
10. Granfors, K. 1992. Do bacterial antigens cause reactive arthritis? Rheum. Dis. Clin. North Am. 18:37-48.
11. Grumet, F. C., B. M. Fendly, and F. G. Engleman. 1981. Monoclonal antiHLA-B27 antibody (B27M1): production and lack of detectable typing difference between patients with ankylosing spondylitis. Reiter's syndrome, and normal controls. Lancet ii: 174-176.
12. Grumet, F. C., B. M. Fendly, L. Fish, S. Foung, and E. G. Engleman. 1982. Monoclonal antibody (B27M2) subdividing HLA-B27. Hum. Immunol. 5:61-72.
13. Guo, H. C., D. R. Madden, M. L. Silver, T. S. Jardezky, J. S. Gorga, J. L. Strominger, and D. C. Wiley. 1443. Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A *6801. HLA-A *0201. and HLA-B * 2705. Proc. Natl. Acad. Sci. USA 90:8053-8057.
14. Haynes, B. F., E. G. Reisner, M. E. Hemler, J. L. Strominger, and G. S. Eisenbarth. 1982. Description of monoclonal antibody defining an HLA allotypic determinant that includes specificities within the B5 cross-reacting group. Hum. Immunol. 4:273-285.
15. Hermann, E., D. T. Y. Vu, K.-H. Meyer zum Büschenfeide, and B. Fleischer. 1993. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342:646-650.
16. Hill, A. B., B. C. Barnett, A. J. McMichael, and D. J. McGeuch. 1994. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J. Immunol. 152:2736-2741.
17. Huang, F., E. Hermann, J. Wang, X.-K. Cheng, W. C. Tsai, J. Wen, J. G. Kuijpers, H. Kellner, B. Ackermann, G. Roth, K. M. Williams, D. T. Y. Yu, and R. B. Raybnrne. 1996. A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27- peptide complexes with low stringency for peptide sequences. Infect. Immun. 64:120-127.
18. Kageyama, S., T. J. Tsomides, Y. Sykulev, and H. N. Eisen. 1995. Variation in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses, J. Immunol. 154:567-576.
19. Kapasi, K., and R. D. Inman. 1994. ME1 epitope of HLA-B27 confers class I-mediated modulation of gram-negative bacterial invasion. J. Immunol. 153:833-840.
20. Kirveskari, J., H. Kellner, M. Wuorela, H. Soini, B. Frankenberger, M. Leirisalo-Repo, E. Weiss, and K. Granfors. 1997. False negative HLA-B27 typing results may be due to altered antigenic epitopes and can be detected by PCR. Br. J. Rheumatol. 36:185-189.
21. Koller, B. H., and H. T. Orr. 1985. Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level. J. Immunol. 134:2727-2733.
22. Laemmli, U. K. 1970. Cleavage of structural protein during the assembly of the head of the bacteriophage T4. Nature (London) 227:680-685.
23. Laird, W. J., and D. C. Cavanaugh. 1980. Correlation of autoagglutination and virulence of yersiniae. J. Clin. Microbiol. 11:430-432.
24. Leirisalo-Repo, M., and H. Suoranta. 1988. Ten-year followup study of patients with Yersinia arthritis. Arthritis Rheum. 31:533-537.
25. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1991. The structure of HLA-B27 reveals nonamer self-peptidcs bound in an extended conformation. Nature (London) 353:321-325.
26. McCutcheon, J.-A., and C.-T. Lutz. 1992. Mutagenesis around residue 176 on HLA-B*0702 characterizes multiple distinct epitopes for anti-HLA antibodies. Hum. Immunol. 35:125-131.
27. McCutcheon, J. A., K. D. Smith, A. Valenzuela, K. Aalbers, and C. T. Lutz. 1993. HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues. Hum. Immunol. 36:69-75.
28. Neefjes, J. J., and H. L. Ploegh. 1988. Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with β2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur. J. Immunol. 18:801-810.
29. Neumüller, J., M. Fisher, and R. Eberl. 1993. Failure of the seroiogical determination of HLA-B27 due to antigen masking in patients with ankylosing spondylitis. Rheumatol. Int. 13:163-167.
30. Parham, P., P. Antonelli, L. A. Herzenberg, T. J. Kipps, A. Fuller, and F. E. Ward. 1986. Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies. Hum. Immunol. 15:44-67.
31. Parham, P., C. J. Barnstable, and W. F. Bodmer. 1979. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C antigens. J. Immunol. 123:342-347.
32. Parham, P., and F. M. Brodsky. 1981. Partial purification and some prop erties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Mum. Immunol. 3:277-299.
33. Pei, P., K. Arjomand-Shamsai, C. T. Deng, A. Cesbron, J. D. Bignon, and J.-H. Lee. 1993. A monospecific HLA-B27 fluorescein isothiocyanate-conjugated monoclonal antibody for rapid, simple and accurate HLA-B27 typing. Tissue Antigens 41:200-203.
34. Keid, P. A., and C. Watts. 1990. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature (London) 346:655-657.
35. Ringrose, J. H., H. A. Yard, A. Muijsers, C. J. P. Boog, and T. E. W. Feltkamp. 1996. Comparison of peptides eluted from the groove of HLA- B27 from Salmonella infected and noninfected cells. Clin. Rheumatol. 15(Suppl. 1):74-78.
36. Salmi, M., and S. Jalknnen. 1992. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257:1407-1409.
37. Sulter, R. D., C. Clayberger, C. E. Lomen, A. M. Krensky, and P. Parham. 1987. In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule. J. Exp. Med. 166:283-288.
38. Santos-Aguado, J., J. A. Barbosa, P. A. Biro, and J. L. Strominger. 1988. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule. J. Immunol. 141:2811-2818.
39. Strvhn, A., L. O. Pedersen, T. Romme, A. C. Olsen, M. H. Nissen, C. J. Thorpe, and S. Buus. 1996. pH dependence of MHC class I-restricted peptide presentation. J. Immunol. 156:4191-4197.
40. Sundström, C., and K. Nilsson. 1976, Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17:565-577.
41. Swincow, T. D. V. 1989. Statistics at square one. Latimer Trend & Company Ltd., Plymouth, United Kingdom.
42. Taurog, J. D., and F. A. K. El-Zaatari. 1988. In vitro mutagenesis of HLA- B27. Substitution of an unpaired cysteine residue in the α1 domain causes loss of antibody-defined epitopes. J. Clin. Invest. 82:987-992.
43. Taurog, J. D., L. Lowen, J. Forman, and R. E. Hammer. 1988. HLA-B27 in inbred and non-inbred mice. Cell surface expression and recognition as an alloantigen in the absence of human β2-microglobulin, J. Immunol. 141: 4020-4023.
44. Toubert, A., C. Raffoux, J. Boretto, J. Sire, R. Sodoyer, S. R. Thurau, B. Amor, J. Colombani, F. A. Lemonnier, and B. R. Jordan. 1988. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants. J. Immunol. 141:2503-2509.
45. Trapani, J. A., H. A. Vaugham, R. L. Sparrow, B. D. Tait, and I. F. C. McKenzie. 1983. Description of a mouse monoclonal anti-HLA-B27 antibody HLA-ABC-m3. Hum. Immunol. 7:205-216.
46. Vega, M. A., A. Ezquerra, S. Rojo, P. Aparicio, R. Bragado, and J. A. Lòpez de Castro. 1985. Structural analysis of an HLA-B27 functional variant: identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes. Proc. Natl. Acad. Sci. USA 82:7394-7398.
47. Villanueva, M. S., C. J. M. Backers, and E. G. Pamer. 1994. Infection with Listeria monocytogenes impairs sialic acid addition to host cell glycoproteins. J. Exp. Med. 180:2137-2145.
48. Virtala, M., J. Kirveskari, and K. Granfors. 1994. HLA-B27 modulates intracellular life of Salmonella in transfected L cells. Arthritis Rheum. 37(Suppl.):S224. (Abstract.)
49. Wang, J., D. T. Y. Yu, T. Fukazawa, H. Kellner, J. Wen, X.-K. Cheng, G. Roth, K. M. Williams, and R. B. Raybourne. 1994. A monoclonal antibody that recognizes HLA-B27 in the context of peptides. J. Immunol. 152:1197- 1205.
50. Wen, J., J. Wang, J. G. Kuijpers, F. Huang, K. M. Williams, R. B. Rayborne, and D. T. Yu. 1994. Analysis of HLA-B*2705 peptide motif using T2 cells and mononuclear antibody ME1. Immunogenetics 39:444-446.
51. Whelan, M. A., and J. R. Archer. 1994. Chemical reactivity of an HLA-B27 thiol group. Eur. J. Immunol. 23:3278-3285.
52. Wuorela, M., S. Jalkanen, P. Toivanen, and K. Granfors. 1993. Yersinia lipopolysaccharide is modified by human monocytes. Infect. Immun. 61: 5261-5270.